# Title

 Food and Drugs. PART 357â€”MISCELLANEOUS INTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE


# ID

 CFR-2018-title21-vol5.Pt. 357


# Structured Analysis Summary

| Type        | Values                                                                                                                                      |
|:------------|:--------------------------------------------------------------------------------------------------------------------------------------------|
| Constraints | ['not to exceed', 'before', 'after', 'prior to', 'within', 'exceed']                                                                        |
| Duration    | ['2.0 year', '12.0 year', '20.0 minute']                                                                                                    |
| Condition   | ['subject to', 'when', 'if', 'unless']                                                                                                      |
| Entities    | ['Scope', 'Medication', 'Cholecystokinetic', 'Stir', 'Bismuth', 'Indication', 'Food', 'Indications', 'Children', 'Package', 'Anthelmintic'] |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                           |
|:--------------|:------------------------------------------------------------------------------------------------------------------|
| within        | of the product is pyrantel pamoate when used within  the dosage limits established in &#167;&#8201;357.150(d)(1). |
| after         | nausea, vomiting, diarrhea, headache, or dizziness sometimes occur after  taking this drug.                       |
| not to exceed | or 11 milligrams per kilogram, of body weight not to exceed  1 gram.                                              |
| before        | following dosage schedule: (2) &#8220;Read package insert carefully before  taking this medication.               |
| exceed        | Take only according to directions and do not  exceed  the recommended dosage unless directed by a doctor.         |
| before        | If any worms other than pinworms are present  before  or after treatment, consult a doctor.                       |
| after         | worms other than pinworms are present before or after  treatment, consult a doctor.                               |
| after         | If any symptoms or pinworms are still present  after  treatment, consult a doctor.                                |
| prior to      | Use of a laxative is not necessary  prior to , during, or after medication.&#8221;                                |
|               |               (e) Optional wording.                                                                               |
| after         | laxative is not necessary prior to, during, or after  medication.&#8221;                                          |
|               |               (e) Optional wording.                                                                               |
| before        | a statement that pinworms must be visually identified before  taking this medication.                             |
| within        | consists of any of the following when used within the specified concentration and dosage form established for     |
| before        | (i) &#8220;Shake well  before using.&#8221; (ii) Oral dosage is 60 milliliters 20                                 |
| before        | (i) &#8220;Shake well  before using.&#8221; (ii) Oral dosage is 60 milliliters 20                                 |
| before        | Stir briskly to prepare a suspension  before  using.                                                              |
| before        | Drink 20 minutes  before diagnostic gallbladder x-ray or as directed by a                                         |
| within        | consists of either of the following when used within the dosage limits established for each ingredient in         |
| exceed        | Do not  exceed  300 milligrams daily.                                                                             |


## Duration

| Duration    | Context                                                                                                                                                                                                                                                  |
|:------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 12.0 year   | The labeling of the product contains the following information under the heading &#8220;Directions&#8221;:                                                                                                                                               |
|             |               (1) Adults, children 12 years of age and over, and children 2 years to under 12 years of age: Oral dosage is a single dose of 5 milligrams of pyrantel base per pound, or 11 milligrams per kilogram, of body weight not to exceed 1 gram. |
| 2.0 year    | The labeling of the product contains the following information under the heading &#8220;Directions&#8221;:                                                                                                                                               |
|             |               (1) Adults, children 12 years of age and over, and children 2 years to under 12 years of age: Oral dosage is a single dose of 5 milligrams of pyrantel base per pound, or 11 milligrams per kilogram, of body weight not to exceed 1 gram. |
| 12.0 year   | The labeling of the product contains the following information under the heading &#8220;Directions&#8221;:                                                                                                                                               |
|             |               (1) Adults, children 12 years of age and over, and children 2 years to under 12 years of age: Oral dosage is a single dose of 5 milligrams of pyrantel base per pound, or 11 milligrams per kilogram, of body weight not to exceed 1 gram. |
| 20.0 minute | (i) &#8220;Shake well before using.&#8221;                                                                                                                                                                                                               |
|             |               (ii) Oral dosage is 60 milliliters 20 minutes before diagnostic gallbladder x-ray or as directed by a doctor.                                                                                                                              |
| 20.0 minute | Drink 20 minutes before diagnostic gallbladder x-ray or as directed by a doctor.                                                                                                                                                                         |
| 12.0 year   | Adults and children 12 years of age and over: Oral dosage is 200 to 400 milligrams up to 4 times daily.                                                                                                                                                  |
| 12.0 year   | Children under 12 years of age: consult a doctor.                                                                                                                                                                                                        |
| 12.0 year   | Adults and children 12 years of age and over: Oral dosage is 100 to 200 milligrams daily in divided doses as required.                                                                                                                                   |
| 12.0 year   | Children under 12 years of age: consult a doctor.                                                                                                                                                                                                        |


## Condition

| Condition   | Context                                                                                                                                     |
|:------------|:--------------------------------------------------------------------------------------------------------------------------------------------|
| if          | as safe and effective and is not misbranded if it meets each condition in this subpart and                                                  |
| unless      | Regulations are to chapter I of title 21 unless  otherwise noted.                                                                           |
| when        | active ingredient of the product is pyrantel pamoate when  used within the dosage limits established in &#167;&#8201;357.150(d)(1).         |
| if          | product contains the established name of the drug, if  any, and ident                                                                       |
| subject to  | may also be used, as provided in &#167;&#8201;330.1(c)(2), subject to the provisions of section 502 of the act                              |
| unless      | have liver disease, do not take this product unless  directed by a doctor.&#8221;                                                           |
|             |               (d) Directions.                                                                                                               |
| unless      | directions and do not exceed the recommended dosage unless  directed by a doctor.                                                           |
| unless      | as a single dose; do not repeat treatment unless  directed by a doctor.                                                                     |
| unless      | has pinworms, the entire household should be treated unless  otherwise advised.                                                             |
| if          | as safe and effective and is not misbranded if it meets each of the conditions in this                                                      |
| unless      | Regulations are to chapter I of title 21 unless  otherwise noted.                                                                           |
| when        | the product consists of any of the following when used within the specified concentration and dosage form                                   |
| if          | product contains the established name of the drug, if  any, and ident                                                                       |
| subject to  | may also be used, as provided in &#167;&#8201;330.1(c)(2), subject to the provisions of section 502 of the act                              |
| when        | statements under the heading &#8220;Directions&#8221;: (1) &#8220;Take only when instructed by a doctor:&#8221; (2) For products containing |
| if          | as safe and effective and is not misbranded if it meets each condition in this subpart and                                                  |
| unless      | Regulations are to chapter I of title 21 unless  otherwise noted.                                                                           |
| when        | the product consists of either of the following when used within the dosage limits established for each                                     |
| if          | product contains the established name of the drug, if  any, and ident                                                                       |
| subject to  | used, as provided in &#167;&#8201;330.1(c)(2) of this chapter, subject to the provisions of section 502 of the Federal                      |


## Entities

| Entities          | Context                                                                                                                          |
|:------------------|:---------------------------------------------------------------------------------------------------------------------------------|
| Food              | Food  and Drugs.                                                                                                                 |
| Scope             | Scope .                                                                                                                          |
| Anthelmintic      | Anthelmintic .                                                                                                                   |
| Indication        | of the product states, under the heading &#8220; Indication ,&#8221; the following: &#8220;For the treatment of pinworms.&#8221; |
| Medication        | Medication should only be taken on time as a                                                                                     |
| Package           | Package  inserts for anthelmintic drug products.                                                                                 |
| Scope             | indication: &#8220;For the treatment of common roundworm infestation.&#8221; Scope .                                             |
| Cholecystokinetic | Cholecystokinetic  drug product.                                                                                                 |
| Cholecystokinetic | Cholecystokinetic  active ingredients.                                                                                           |
| Indications       | of the product states, under the heading &#8220; Indications ,&#8221; the following: &#8220;For the contraction of the           |
| Stir              | Stir  briskly to prepare a suspension before using.                                                                              |
| Scope             | &#8220;For visualization of biliary ducts during cholecystography.&#8221;                                                        |
|                   |                Scope .                                                                                                           |
| Bismuth           | limits established for each ingredient in &#167;&#8201;357.850(d): (a) Bismuth  subgallate.                                      |
| Indications       | of the product states, under the heading &#8220; Indications ,&#8221; any of the phrases listed in paragraph                     |
| Children          | Children  under 12 years of age: consult a doctor.                                                                               |
| Children          | Children  under 12 years of age: consult a doctor.                                                                               |


